PLoS neglected tropical diseases· 2014Q1· Review
Mycetoma Medical Therapy
- 174citations
- Q1SCImago
- 2014year
Short summary
This review evaluates current antimicrobial and antifungal drug responses for actinomycetoma and eumycetoma, respectively, highlighting diagnostic confusion that leads to ineffective treatment.
AI-generated from the title and abstract; the full text is not read.
Key points
- Mycetoma diagnosis is challenging due to overlapping clinical features of fungal and bacterial forms.
- Incorrect diagnosis leads to non-response to therapy.
- The review examines current drug responses for both actinomycetoma and eumycetoma.
AI-generated from the title and abstract; the full text is not read.
Abstract
Medical treatment of mycetoma depends on its fungal or bacterial etiology. Clinically, these entities share similar features that can confuse diagnosis, causing a lack of therapeutic response due to inappropriate treatment. This review evaluates the response to available antimicrobial agents in actinomycetoma and the current status of antifungal drugs for treatment of eumycetoma.
The authors' abstract, as published at the source. PLoS neglected tropical diseases, 2014 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Microbiology
MicrobiologyMedicine